1907 Stock Overview
Produces, sells, and distributes coke, coking chemicals, and refined chemicals in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 1/6 |
China Risun Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$2.99 |
52 Week High | HK$3.73 |
52 Week Low | HK$2.93 |
Beta | 0.70 |
11 Month Change | 0% |
3 Month Change | -2.92% |
1 Year Change | -18.08% |
33 Year Change | -39.72% |
5 Year Change | n/a |
Change since IPO | 4.91% |
Recent News & Updates
Recent updates
Shareholder Returns
1907 | HK Chemicals | HK Market | |
---|---|---|---|
7D | 0% | -0.08% | -0.8% |
1Y | -18.1% | -0.9% | -1.1% |
Return vs Industry: 1907 underperformed the Hong Kong Chemicals industry which returned -0.9% over the past year.
Return vs Market: 1907 underperformed the Hong Kong Market which returned -1.1% over the past year.
Price Volatility
1907 volatility | |
---|---|
1907 Average Weekly Movement | 2.4% |
Chemicals Industry Average Movement | 6.0% |
Market Average Movement | 7.0% |
10% most volatile stocks in HK Market | 14.9% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 1907 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1907's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 7,601 | Xuegang Yang | www.risun.com |
China Risun Group Limited, together with its subsidiaries, produces, sells, and distributes coke, coking chemicals, and refined chemicals in the People’s Republic of China. The company operates in four segments: Coke and Coking Chemicals Manufacturing, Refined Chemicals Manufacturing, Operation Management, and Trading. Its coking and refined chemical products include crude benzene, industrial naphthalene phthalic anhydride, coke oven gas methanol, coal-tar pitch, high purified hydrogen, and caprolactam.
China Risun Group Limited Fundamentals Summary
1907 fundamental statistics | |
---|---|
Market cap | HK$13.15b |
Earnings (TTM) | HK$925.07m |
Revenue (TTM) | HK$49.50b |
14.2x
P/E Ratio0.3x
P/S RatioIs 1907 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1907 income statement (TTM) | |
---|---|
Revenue | CN¥46.07b |
Cost of Revenue | CN¥42.74b |
Gross Profit | CN¥3.32b |
Other Expenses | CN¥2.46b |
Earnings | CN¥860.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.20 |
Gross Margin | 7.22% |
Net Profit Margin | 1.87% |
Debt/Equity Ratio | 177.6% |
How did 1907 perform over the long term?
See historical performance and comparison